Fibrinolytic Changes in Women with Preeclampsia

Clin Appl Thromb Hemost. 2022 Jan-Dec:28:10760296221126172. doi: 10.1177/10760296221126172.

Abstract

Objectives: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE.

Aim: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE.

Design and methods: 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed.

Results: Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p = 0.0004 p = 0.04, p = 0.03, p < 0.0001 respectively.

Conclusion: This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy.

Keywords: PAI-2; fibrin lysability; fibrinolysis; preeclampsia; protein polymerization.

MeSH terms

  • Antifibrinolytic Agents*
  • Carboxypeptidase B2*
  • Dextran Sulfate / pharmacology
  • Female
  • Fibrin
  • Fibrinogen / pharmacology
  • Fibrinolysis
  • Humans
  • Plasminogen / pharmacology
  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activator Inhibitor 2 / pharmacology
  • Pre-Eclampsia*
  • Pregnancy
  • Thrombosis*
  • Tissue Plasminogen Activator

Substances

  • Antifibrinolytic Agents
  • Carboxypeptidase B2
  • Dextran Sulfate
  • Fibrin
  • Fibrinogen
  • Plasminogen
  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activator Inhibitor 2
  • Tissue Plasminogen Activator